Pacific Biosciences of California Inc
SWB:P09
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacific Biosciences of California Inc
SWB:P09
|
US |
|
T
|
Tencent Holdings Ltd
F:NNND
|
CN |
|
N
|
Nomura Holdings Inc
XBER:NSE
|
JP |
|
M
|
Medallion Financial Corp
SWB:MD5
|
US |
|
Iridium Communications Inc
NASDAQ:IRDM
|
US |
|
M
|
Microsoft Corp
XHAM:MSF
|
US |
|
C
|
ConvaTec Group PLC
OTC:CNVVF
|
UK |
|
A
|
Arrow Electronics Inc
XMUN:ARW
|
US |
|
I
|
Illumina Inc
XMUN:ILU
|
US |
Wall St Price Targets
P09 Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for P09 is 1.9765 EUR with a low forecast of 1.0675 EUR and a high forecast of 2.6634 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is P09's stock price target?
Price Target
1.9765
EUR
According to Wall Street analysts, the average 1-year price target for P09 is 1.9765 EUR with a low forecast of 1.0675 EUR and a high forecast of 2.6634 EUR.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 26%.
